Physician profile
Sergey Lyass
NPI 1316996911
$71,148.58
in general payments reported to CMS, 2019-2025
32 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $202 · 2021: $16K · 2022: $15K · 2023: $10K · 2024: $791 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $2,678 · Travel and Lodging: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $2,677.96 |
| Travel and Lodging | $591.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $64,611.81 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $1,662.69 | 2021-2025 | Ligasure, Signia |
| Apollo Endosurgery US INC | $995.77 | 2019-2022 | |
| Teleflex LLC | $909.58 | 2023-2025 | Titan Sgs Standard Gastric Stapler, Titan Sgs, Titan Sgs Bailout Chuck |
| Boston Scientific Corporation | $495.13 | 2019-2025 | Ams 700, General - Pain Management, Solyx Sis System |
| New Wave Endo-Surgical Corp. | $464.00 | 2022 | |
| Covidien Lp | $422.93 | 2019 | |
| Bard Access Systems, INC. | $231.64 | 2019 | |
| Coloplast Corp | $202.27 | 2021-2024 | Titan |
| Aesculap, INC. | $163.92 | 2021 | |
| Polynovo North America LLC | $114.68 | 2024 | Novosorb Btm |
| Dendreon Pharmaceuticals LLC | $98.11 | 2021 | |
| Amgen INC. | $89.82 | 2019-2021 | |
| Novo Nordisk INC | $65.43 | 2022-2024 | Wegovy |
| Ethicon US, LLC | $65.26 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $59.61 | 2020-2025 | |
| Lilly USA, LLC | $55.59 | 2023-2024 | Zepbound, Taltz |
| Takeda Pharmaceuticals U.S.A., INC. | $46.80 | 2019 | |
| Astellas Pharma US INC | $45.80 | 2020-2024 | Veozah |
| Mimedx Group, INC. | $36.56 | 2024 | |
| Metuchen Pharmaceuticals | $34.64 | 2019 | |
| Cook Medical LLC | $32.25 | 2019 | |
| Antares Pharma, INC. | $29.96 | 2019 | |
| Acerus Pharmaceuticals Corporation | $29.50 | 2020 | |
| Urogen Pharma, INC. | $29.41 | 2023 | Jelmyto |
| Axonics, INC. | $25.72 | 2022 | |
| Agiliti Surgical, INC. | $25.16 | 2025 | Sonablate Hifu, Olympus Soltive Tfl Laser, Koelis Trinity Mri/US Fusion |
| Progenics Pharmaceuticals, INC. | $24.28 | 2023 | Pylarify |
| C. R. Bard, INC. & Subsidiaries | $23.99 | 2023 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $21.46 | 2025 | Gemtesa |
| Standard Bariatrics, INC. | $17.98 | 2022 | |
| Acell, INC. | $16.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Lyass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.